KNOWLEDGE BANK

Interviews

Knowledge Gain Through High Parallel Bioprocess Setups

Product Life Cycle Manager, Eppendorf AG
Sebastian Kleebank studied Bioengineering at the University of Applied Sciences in Juelich followed by his PhD at the RWTH Aachen Institute for Molecular Biotechnology In his actual position as a Product Life Cycle Manager at Eppendorf AG Business Unit Bioprocess he is responsible for the smallscale product portfolio During his years in the bioprocess industry he gained a lot of experience in sma...

Articles

Homeopathic Science

Homeopathy a controversial medical system discovered by a German physician Samuel Hahnemann was first postulated at the end of the th century and mentioned in the first edition of his Organon in In such anecdotal times where theories about the deficiency four bodily fluids theories about corrupted juices were propagating against all odds the beginning of prescientific medical theories were bo...

Research Insights

A Simple And Sensitive Method To Analyze Genotoxic Impurity Hydrazine In Pharmaceutical Materials

Abstract Hydrazine NH is a known genotoxic impurity that typically needs to be controlled down to low ppm level in pharmaceutical development Hydrazine however is a challenging molecule to analyze using conventional analytical techniques due to its physical and chemical properties eg lack of chromophore absence of any carbon atom low molecular weight h

Case Studies

External Innovation Implementation Determinants and Performance Measurement: A Case Study from the Pharmaceutical Industry

Abstract With an increasing amount of externally sourced innovations a major success factor for innovationdependent industries such as the pharmaceutical industry is to successfully implement innovations from outside Existing frameworks emphasize creating a strong climate for implementation by developing the learning capabilities of the organization but the

Techno Trends

Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough Designation"

Sanofi and Regeneron announced that Cemiplimab REGN has received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Cemiplimab is an investigational human monoclonal antibody targeting PD It would be used to treat adults with metastatic cutaneous squamous cell carcinoma CSCC and adults with locally advanced and unresectable CSCC the...

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Application of Artificial Intelligence in Development Safety Update Report Preparation

Maria Carolina Braga

Maria Carolina Braga holds a degree in Pharmaceutical Sciences with a specialization in Clinical Pharmacy. She has over 10 years of experience in pharmacovigilance and recently completed a master’s degree in Pharmacovigilance and Pharmacoepidemiology, focusing her research on the use of artificial intelligence in aggregate safety report writing.

2

Alpha-fetoprotein as a Shuttle for Medicines

Vladimir N Pak

Vladimir Pak received his Ph.D. from the Institute of Bioorganic Chemistry, Moscow. He modernized technologies and manufactured APIs for the known drugs. Invented anticancer drug candidates based on alpha-fetoprotein that can be used as injectable or orally. Developed supplements to treat stomach ulcers and IBD.

 

3

Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products

Natalja Genina

Natalja Genina, Associate professor at University of Copenhagen (UCPH), Denmark. Her research interest include fabrication of advanced drug delivery systems and their integration into digital health. Dr. Genina has a remarkable publication record in her research field.

 

Jukka Rantanen

Professor, UCPH

Johan Bøtker

Associate Professor, UCPH

Sofia Kalvemark Sporrong

Sofia Kälvemark Sporrong, Professor at Uppsala University, Sweden. Expert in social pharmacy. Kälvemark Sporrong is a social scientist doing research within the area of pharmaceuticals. Her research interests include the patient perspective on drug use, pharmaceutical policy and professional ethics for health care staff.

 

4

Chronic Wound Healing Properties In Magical Potion Of Lemongrass Herb

Krishnendu Adhikary

Krishnendu Adhikary is working as Assistant Professor and Head of Department of Medical Lab Technology, Paramedical College Durgapur, West Bengal, India. He is working on phytochemical analysis, chronic wound repair. He has published 32 articles, 07 patents. He has received Junior Scientist Award under National Environmental Science Academy (DST, India).

 

Pradipta Banerjee

Dr. Pradipta Banerjee is working as a postdoctoral associate in the University of Pittsburgh, USA. He has two years of teaching experience as an Assistant Professor in the Centurion University, India and ten years of research experience. His area of interest is macrophage biology, chronic wound healing and tissue regeneration.

 

5

Nanotechnology based Drug Delivery for Infectious Diseases

Dr. Vinod Kumar Rajana

Dr. Vinod Kumar Rajana, Assistant Professor of Pharmaceutics, specializes in nanotechnology, bioassays, and infectious disease research. With expertise in nanoparticle synthesis, biotechnology, and drug delivery, his work integrates green chemistry with pharmaceutical innovation to develop sustainable, low-cost nanomaterials for topical antifungal and anticancer therapies, water purification, and biomedical applications.

press releasesRead more...

Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

Oracle Life Sciences announced a partnership with Wipro Limited a leading AIpowered technology services and consulting company to strengthen Wipros pharmacovigilance PV service offering using Oracle Life

Grünenthal acquires cancer treatment Stivarga®

Grnenthal a global leader in pain management and research today announced an agreement with Bayer AG to acquire Stivarga an oral treatment for specific advanced cancers for up to million

Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

Kazia Therapeutics Limited NASDAQ KZIA an oncologyfocused biotechnology company developing therapies that selectively reprogram cancer biology restore antitumor immunity and overcome treatment resistance

Merck Introduces ‘Science Behind Water’ Campaign to Promote Safe Water Practices

Merck a leading science and technology company launched the Science Behind Water campaign an initiative designed to build awareness around the importance of water quality safety hygiene

AISB Network Launches AISB Bind to Improve Prediction of How Molecules Bind for Virtual Screening and Lead Optimization

The AI Structural Biology AISB Network powered by Apheris today launched AISB Bind a new federated initiative through which AbbVie AstraZeneca Bristol Myers Squibb and Johnson Johnson

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

Telix Pharmaceuticals Limited ASX TLX NASDAQ TLX Telix today announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE ITM a global leader

EventsRead more...

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

LATEST NEWSRead more...

TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation

TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures

SK pharmteco and GEMMABio Expand Manufacturing Collaboration for SMA Gene Therapy

SK pharmteco and Gemma Biotherapeutics GEMMABio have expanded their manufacturing collaboration to support the clinical development of GB an investigational gene therapy for spinal muscular atrophy type SMA

Merck’s KEYTRUDA QLEX Approved for Subcutaneous Administration

Merck has announced that Japans Ministry of Health Labour and Welfare MHLW has approved KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfapmph for subcutaneous administration

Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases

Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases

Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease

Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD

QurCan Therapeutics Enters into Collaboration with Lilly Advance Nucleic Acid Therapies for Nervous System Diseases

QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop nucleic acid therapies for diseases affecting the central nervous system CNS and peripheral nervous system PNS